Skip to main content
High RiskFDAfda-F-1046-2019CONTAMINATION

CTFO Pain Relief Oral Spray with pure CBD Hemp Oil isolate Dietary Supplement, 1oz/30ml.

Category
Units Affected
840
Recall Date
January 11, 2019
Issuing Agency
Hazard
Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1046-2019.

Recalling firm's consignee conducted third party micro testing showing microbial contamination in specific lots of the following products: CTFO Sleep Support Oral Spray (Aspergillus), CTFO Pain Relief Oral Spray (total aerobic bacteria), and CTFO Weight Loss Oral Spray (Enterobacteriaceae).

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1046-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Nutrafuels, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1046-2019.

Nutrafuels, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Nutrafuels, Inc. Recall FAQ

Nutrafuels, Inc. is the subject of a supplements safety report: CTFO Pain Relief Oral Spray with pure CBD Hemp Oil isolate Dietary Supplement, 1oz/30ml.. The notice was published on January 11, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 840 units are potentially affected.